排序方式: 共有7条查询结果,搜索用时 15 毫秒
1
1.
Naiara Akizu Nuri?M. Shembesh Tawfeg Ben-Omran Laila Bastaki Asma Al-Tawari Maha?S. Zaki Roshan Koul Emily Spencer Rasim?Ozgur Rosti Eric Scott Elizabeth Nickerson Stacey Gabriel Gilberto da?Gente Jiang Li Matthew?A. Deardorff Laura?K. Conlin Margaret?A. Horton Elaine?H. Zackai Elliott?H. Sherr Joseph?G. Gleeson 《American journal of human genetics》2013,92(3):392-400
The corpus callosum is the principal cerebral commissure connecting the right and left hemispheres. The development of the corpus callosum is under tight genetic control, as demonstrated by abnormalities in its development in more than 1,000 genetic syndromes. We recruited more than 25 families in which members affected with corpus callosum hypoplasia (CCH) lacked syndromic features and had consanguineous parents, suggesting recessive causes. Exome sequence analysis identified C12orf57 mutations at the initiator methionine codon in four different families. C12orf57 is ubiquitously expressed and encodes a poorly annotated 126 amino acid protein of unknown function. This protein is without significant paralogs but has been tightly conserved across evolution. Our data suggest that this conserved gene is required for development of the human corpus callosum. 相似文献
2.
Naiara Akizu Jennifer L. Silhavy Rasim Ozgur Rosti Eric Scott Ali G. Fenstermaker Jana Schroth Maha S. Zaki Henry Sanchez Neerja Gupta Madhulika Kabra Majdi Kara Tawfeg Ben-Omran Basak Rosti Alicia Guemez-Gamboa Emily Spencer Roger Pan Na Cai Mostafa Abdellateef Stacey Gabriel Jan Halbritter Friedhelm Hildebrandt Hans van Bokhoven Murat Gunel Joseph G. Gleeson 《American journal of human genetics》2014
3.
Anastasio N Ben-Omran T Teebi A Ha KC Lalonde E Ali R Almureikhi M Der Kaloustian VM Liu J Rosenblatt DS Majewski J Jerome-Majewska LA 《American journal of human genetics》2010,87(4):553-559
Van Den Ende-Gupta syndrome (VDEGS) is an extremely rare autosomal-recessive disorder characterized by distinctive craniofacial features, which include blepharophimosis, malar and/or maxillary hypoplasia, a narrow and beaked nose, and an everted lower lip. Other features are arachnodactyly, camptodactyly, peculiar skeletal abnormalities, and normal development and intelligence. We present molecular data on four VDEGS patients from three consanguineous Qatari families belonging to the same highly inbred Bedouin tribe. The patients were genotyped with SNP microarrays, and a 2.4 Mb homozygous region was found on chromosome 22q11 in an area overlapping the DiGeorge critical region. This region contained 44 genes, including SCARF2, a gene that is expressed during development in a number of mouse tissues relevant to the symptoms described above. Sanger sequencing identified a missense change, c.773G>A (p.C258Y), in exon 4 in the two closely related patients and a 2 bp deletion in exon 8, c.1328_1329delTG (p.V443DfsX83), in two unrelated individuals. In parallel with the candidate gene approach, complete exome sequencing was used to confirm that SCARF2 was the gene responsible for VDEGS. SCARF2 contains putative epidermal growth factor-like domains in its extracellular domain, along with a number of positively charged residues in its intracellular domain, indicating that it may be involved in intracellular signaling. However, the function of SCARF2 has not been characterized, and this study reports that phenotypic effects can be associated with defects in the scavenger receptor F family of genes. 相似文献
4.
5.
J Haeberle N Shahbeck K Ibrahim B Schmitt I Scheer R O'Gorman FA Chaudhry T Ben-Omran 《Orphanet journal of rare diseases》2012,7(1):48
ABSTRACT: Glutamine synthetase (GS) is ubiquitously expressed in mammalian organisms and is a key enzyme in nitrogen metabolism. It is the only known enzyme capable of synthesising glutamine, an amino acid with many critical roles in the human organism. A defect in GLUL, encoding for GS, leads to congenital systemic glutamine deficiency and has been described in three patients with epileptic encephalopathy. There is no established treatment for this condition. Here, we describe a therapeutic trial consisting of enteral and parenteral glutamine supplementation in a four year old patient with GS deficiency. The patient received increasing doses of glutamine up to 1020 mg/kg/day. The effect of this glutamine supplementation was monitored clinically, biochemically, and by studies of the electroencephalogram (EEG) as well as by brain magnetic resonance imaging and spectroscopy. Treatment was well tolerated and clinical monitoring showed improved alertness. Concentrations of plasma glutamine normalized while levels in cerebrospinal fluid increased but remained below the lower reference range. The EEG showed clear improvement and spectroscopy revealed increasing concentrations of glutamine and glutamate in brain tissue. Concomitantly, there was no worsening of pre-existing chronic hyperammonemia. In conclusion, supplementation of glutamine is a safe therapeutic option for inherited GS deficiency since it corrects the peripheral biochemical phenotype and partially also improves the central biochemical phenotype. There was some clinical improvement but the patient had a long standing severe encephalopathy. Earlier supplementation with glutamine might have prevented some of the neuronal damage. 相似文献
6.
Julie Jerber Maha S. Zaki Jumana Y. Al-Aama Rasim Ozgur Rosti Tawfeg Ben-Omran Esra Dikoglu Jennifer L. Silhavy Caner Caglar Damir Musaev Beate Albrecht Kevin P. Campbell Tobias Willer Mariam Almuriekhi Ahmet Okay Çağlayan Jiri Vajsar Kaya Bilgüvar Gonul Ogur Rami Abou Jamra Murat Günel Joseph G. Gleeson 《American journal of human genetics》2016,99(5):1181-1189
7.
Naiara Akizu Jennifer?L. Silhavy Rasim?Ozgur Rosti Eric Scott Ali?G. Fenstermaker Jana Schroth Maha?S. Zaki Henry Sanchez Neerja Gupta Madhulika Kabra Majdi Kara Tawfeg Ben-Omran Basak Rosti Alicia Guemez-Gamboa Emily Spencer Roger Pan Na Cai Mostafa Abdellateef Stacey Gabriel Jan Halbritter Friedhelm Hildebrandt Hans van?Bokhoven Murat Gunel Joseph?G. Gleeson 《American journal of human genetics》2014,94(1):80-86
Joubert syndrome and related disorders (JSRDs) are genetically heterogeneous and characterized by a distinctive mid-hindbrain malformation. Causative mutations lead to primary cilia dysfunction, which often results in variable involvement of other organs such as the liver, retina, and kidney. We identified predicted null mutations in CSPP1 in six individuals affected by classical JSRDs. CSPP1 encodes a protein localized to centrosomes and spindle poles, as well as to the primary cilium. Despite the known interaction between CSPP1 and nephronophthisis-associated proteins, none of the affected individuals in our cohort presented with kidney disease, and further, screening of a large cohort of individuals with nephronophthisis demonstrated no mutations. CSPP1 is broadly expressed in neural tissue, and its encoded protein localizes to the primary cilium in an in vitro model of human neurogenesis. Here, we show abrogated protein levels and ciliogenesis in affected fibroblasts. Our data thus suggest that CSPP1 is involved in neural-specific functions of primary cilia. 相似文献
1